دوره 1، شماره 3 - ( 10-1388 )                   جلد 1 شماره 3 صفحات 114-111 | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mobini M. Severe muscle weakness during treatment with pegylated interferon alfa for chronic hepatitis C virus infection A rare complication. Caspian J Intern Med 2010; 1 (3) :111-114
URL: http://caspjim.com/article-1-85-fa.html
Severe muscle weakness during treatment with pegylated interferon alfa for chronic hepatitis C virus infection A rare complication. . 1388; 1 (3) :111-114

URL: http://caspjim.com/article-1-85-fa.html


چکیده:   (8751 مشاهده)
Background: Interferons (IFNs) are common therapeutics for several diseases such as viral hepatitis, multiple sclerosis and malignancy. A variety of autoimmune related side effects have been observed during IFN therapy. Rare cases of myopathy, polymyositis or dermatomyositis have been reported during therapy with high doses of IFNα.
Case Presentation: In this report, we describe a case with severe muscle weakness but near normal muscles' enzymes during treatment of chronic hepatic C infection with pegylated IFN α 2a in a patient with major beta thalassemia
Conclusion: This report suggests that severe weakness with normal musclesα enzymes may occur during IFN therapy.
متن کامل [PDF 128 kb]   (3062 دریافت)    
نوع مطالعه: Original Article | موضوع مقاله: Infectious Diseases
دریافت: 1392/10/24 | پذیرش: 1392/10/24 | انتشار: 1392/10/24

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | Caspian Journal of Internal Medicine

Designed & Developed by : Yektaweb